vTv Therapeutics shares nearly double following HQ news

VTv Therapeutics stock is regaining some of the losses it took after the biotech firm announced disappointing results of a late-stage study of its Alzheimer's drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.